PON2 knockdown in the tumor cell lines K562 (leukemia) and A549 (lung cancer) initiated apoptosis [6], suggesting that PON2 may act as a target for cancer therapy in certain malignancies and fulfill an outstanding function for tumor cell survival. Here, PON2 is linked to cancer.